Fatemeh Gholizadeh | Plant Stress | Women Researcher Award 

Dr. Fatemeh Gholizadeh | Plant Stress | Women Researcher Award 

HUN-REN Centre for Agricultural Research | Hungary 



Orcid ID


Fatemeh Gholizadeh began her academic journey with a Bachelor of Science in Horticulture Sciences from Gorgan University of Agricultural Sciences and Natural Resources. She advanced her studies at the same institution, earning a Master of Science in Plant Biotechnology. Her M.Sc. thesis focused on estimating genetic diversity in rice (Oryza sativa L.) genotypes using SSR markers under salinity stress, showcasing her early interest in plant genetics and stress physiology.


Fatemeh's professional journey is marked by her pursuit of a Ph.D. in Plant Biotechnology from Sanandaj University of Kurdistan. Her doctoral research delved into the identification and study of the polyamine oxidase gene family in wheat (Triticum aestivum) and their expression in response to exogenous polyamines and cold treatment. This work highlights her commitment to understanding plant responses to environmental stresses, a critical area in agricultural biotechnology.


Throughout her academic career, Fatemeh Gholizadeh has contributed significantly to the field of plant biotechnology. Her research primarily focuses on plant genetics, stress physiology, and biotechnology. By investigating the genetic mechanisms underlying plant responses to environmental stresses, she aims to enhance crop resilience and productivity. Her work on polyamine oxidase genes in wheat and genetic diversity in rice underlines her expertise in molecular biology and plant stress responses.


Fatemeh's research has made a notable impact in the scientific community, particularly in the areas of plant stress physiology and genetic diversity. Her studies provide valuable insights into the genetic and molecular basis of plant responses to abiotic stresses, such as salinity and cold. This research is crucial for developing stress-resistant crop varieties, which is essential for ensuring food security in the face of climate change.


Fatemeh Gholizadeh's work has been recognized and cited by peers in the field, reflecting the significance and relevance of her research. Her contributions are documented in various scientific publications and platforms, including her ORCID profile (0000-0002-1518-4629) and Loop profile (2004768). These citations underscore her role in advancing plant biotechnology research.


Looking ahead, Fatemeh Gholizadeh is poised to continue her impactful research in plant biotechnology. Her ongoing work will likely further our understanding of plant genetics and stress responses, contributing to the development of resilient agricultural systems. Her legacy will be defined by her commitment to improving crop performance under adverse conditions, ultimately benefiting global agriculture and food security.


Bin Zhang | Gene Mutation | Best Researcher Award

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China



Google Scholar


Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.


In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.


Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.


The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.


Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.


Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research


Paritha Arumugam | Gene Therapy | Best Researcher Award

Dr. Paritha Arumugam | Gene Therapy | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States



Orcid ID


Paritha Arumugam's academic journey began at the University of Madras, Bharathi Women's College, where she earned her B.Sc. in Biochemistry in 1991. She continued her education at the University of Madras, Guindy Campus, obtaining her M.Sc. in Biochemistry in 1993, M.Phil. in Biochemistry in 1994, and Ph.D. in Biochemistry in 1998 under the mentorship of Shyamala Devi, C.S. Her academic excellence was recognized with numerous awards, including the Gold Medal for securing the first rank in her M.Sc. program and various other prestigious prizes from the University of Madras.


Dr. Arumugam's professional career is marked by significant roles in both academic and research settings. She served as a Postdoctoral Research Fellow at the Children’s Hospital Los Angeles (CHLA) from 2004 to 2006, under the guidance of Dr. Punam Malik in the Division of Hematology-Oncology. She later earned an M.S. in Drug Development from the University of Cincinnati in 2011, where she was advised by Kevin L. Skare. Her academic appointments at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center (CCHMC) have been pivotal. She progressed from Research Instructor in Pediatrics (2015-2019) to her current position as an Assistant Professor in Pediatrics at the Translational Pulmonary Science Center, Division of Pulmonary Biology, beginning in October 2019.


Dr. Arumugam's research has significantly advanced the fields of biochemistry and molecular biology, with a particular focus on translational pulmonary science. Her work on developing a novel cell transplantation therapy, specifically Pulmonary Macrophage Transplantation, earned her a plenary talk at the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research in 2023. Her research has garnered numerous awards, including the Excellence in Hemoglobinopathy Research Award from the National Institutes of Health and multiple abstract and travel awards from the American Society of Hematology.


Dr. Arumugam's impact extends beyond her direct research contributions. Her role in advancing clinical practices is underscored by her licensing and certification in Good Clinical Practice for clinical trials involving drugs and devices. Her expertise in conducting investigator-initiated studies according to FDA regulations and GCP has positioned her as a leader in the field, capable of managing investigational agents and overseeing the ethical conduct of clinical trials.


Dr. Arumugam's academic excellence has been recognized with several citations and awards throughout her career. Notably, she has been a recipient of the Cincinnati Children’s Innovation Excellence Award in 2023 and the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research Poster Award. Her scholarly contributions are also highlighted by her selection as a Translational Sickle Scholar by the National Institutes of Health.


Dr. Arumugam's legacy is defined by her dedication to advancing medical science and improving clinical practices. Her pioneering research on pulmonary macrophage transplantation and her contributions to hemoglobinopathy research underscore her commitment to translational science. Looking forward, Dr. Arumugam aims to continue her impactful research, mentor the next generation of scientists, and contribute to significant advancements in pediatric pulmonary biology and therapeutic developments.


Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Prof Richard Lu | Neurodegenerative Diseases | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

Author Profile


Early Academic Pursuits

Qing Richard Lu embarked on his academic journey with a Bachelor of Science in Biochemistry from Peking Normal University in Beijing, China, which he completed in 1988. Following this, he pursued a Master of Science in Biophysics at Rutgers University, New Jersey, USA, completing his degree in 1993. He continued his studies at Rutgers University, earning a Ph.D. in Biochemistry in 1997 under the mentorship of Dr. Masayori Inouye.

Professional Endeavors

Dr. Lu's professional career began with a postdoctoral fellowship at the Dana-Farber Cancer Institute, Harvard Medical School, from 1997 to 2002. He worked with Dr. Chuck D. Stiles and collaborated with Dr. David Rowitch. In 2002, he joined the UT Southwestern Medical Center as an Assistant Professor in the Department of Developmental Biology, where he held the position of Southwestern Medical Foundation Endowed Scholar in Medical Research. He was promoted to Associate Professor with tenure in 2009 and continued in this role until 2013. In 2013, Dr. Lu joined Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine. He currently holds the position of Professor with tenure in the Department of Pediatrics. Additionally, he serves as the Scientific Director of the Brain Tumor Center and Program Leader of the Brain Tumor Program in the Division of Experimental Hematology and Cancer Biology, Cancer & Blood Diseases Institute.

Contributions and Research Focus on Neurodegenerative Diseases

Dr. Lu's research primarily focuses on the molecular and cellular mechanisms underlying brain tumors. His work is significant in understanding the biology of brain cancer and developing new therapeutic strategies. He has made notable contributions to the field of experimental hematology and cancer biology through his research on brain tumor development, progression, and treatment.

Impact and Influence

Throughout his career, Dr. Lu has influenced the field of pediatric oncology and neurobiology. His research has provided insights into the genetic and biochemical pathways involved in brain tumors, contributing to the development of novel therapeutic approaches. His work has been recognized through various academic appointments and endowed scholarships, reflecting his significant impact on medical research.

Academic Cites

Dr. Lu's work has been widely published in numerous scientific journals, and his research findings are frequently cited by peers in the field. His publications contribute to the broader scientific understanding of brain tumors and their treatment, solidifying his reputation as a leading expert in the field.

Legacy and Future Contributions

As a leading figure in pediatric oncology and neurobiology, Dr. Lu's legacy is marked by his commitment to advancing scientific knowledge and improving patient outcomes. His ongoing research efforts and leadership roles at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine continue to shape the future of brain tumor research and treatment. Dr. Lu’s future contributions are expected to further enhance the understanding and management of brain tumors, paving the way for innovative therapeutic solutions and improved patient care.

Notable Publications 

Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Prof Dr. Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Nanjing Medical University | China



orcid ID


Wei Wu began his academic journey at Nanjing Medical University, where he earned a Bachelor of Science in Preventive Medicine in 2007. He continued his studies at the same institution, obtaining a Ph.D. in Toxicology in 2012. His doctoral research was conducted in the Department of Toxicology, focusing on toxicological mechanisms and their implications for public health. Following his Ph.D., Wu completed a postdoctoral fellowship in Reproductive and Developmental Toxicology at the State Key Laboratory of Reproductive Medicine, also at Nanjing Medical University. In 2017-2018, he broadened his research horizons as a guest researcher at the National Institute of Environmental Health Sciences in the United States, specializing in Epidemiology.


Wei Wu's professional career is anchored at Nanjing Medical University, where he has ascended from a research assistant to a professor. His roles include:

  • 2022-present: Professor, Department of Toxicology, School of Public Health
  • 2022-present: Assistant Dean, School of Public Health
  • 2022-present: Secretary General, Jiangsu Society of Toxicology
  • 2021-present: Associate Department Chair, Department of Scientific Research Sharing Platform (Core Facility)
  • 2018-present: Associate Department Chair, Department of Toxicology
  • 2016-2022: Associate Professor, Department of Toxicology
  • 2012-2016: Lecturer, Department of Toxicology
  • 2010-2012: Research Assistant, School of Public Health


Wei Wu has made significant contributions to the field of toxicology, particularly in reproductive and developmental toxicology. His research has focused on the toxicological effects of environmental and chemical exposures on reproductive health. His work also delves into the molecular mechanisms underlying these toxicological impacts, aiming to develop preventive strategies and therapeutic interventions.


Wei Wu has received numerous honors and awards that reflect his impact and influence in the field of toxicology. Notable accolades include:

  • 2023: "Good Youth Around Us" by the Communist Youth League Jiangsu Provincial Committee
  • 2022: Friendship Teaching Award of Nanjing Medical University
  • 2020: Ministry of Education Fok Ying Tung Young Teachers' Award
  • 2019: Clarivate Publons Peer Review Awards (top 1% reviewers in Crossfield and Clinical Medicine)
  • 2018: Publons Peer Review Awards (top 1% reviewers in Clinical Medicine)
  • 2017: Multiple awards for excellent papers and teaching achievements


Wei Wu holds various editorial positions, contributing to the dissemination of scientific knowledge in toxicology and related fields. He serves on the editorial boards of several prestigious journals, including:

  • Scientific Reports
  • SM Journal of Environmental Toxicology
  • Global Journal of Genitourinary Cancer
  • Austin Journal of Reproductive Medicine & Infertility
  • Journal of Clinical Obstetrics, Gynecology & Infertility
  • Medicine
  • Frontiers in Endocrinology
  • Frontiers in Physiology

As an editor-in-chief, he leads the International Journal of Sexual Health and Reproductive Health Care and the Research International Journal of Endocrinology and Diabetes.


Wei Wu’s ongoing research and professional activities suggest a lasting legacy in the field of toxicology. His leadership roles within professional societies, such as the Jiangsu Society of Toxicology and the Jiangsu Provincial Preventive Medical Association, underline his influence in shaping future research directions and policies. His dedication to teaching and mentoring the next generation of toxicologists ensures that his impact will continue to resonate in the academic and scientific communities.


Ying Yang | Neurodegenerative Disease | Best Researcher Award

Assoc Prof Dr. Ying Yang | Neurodegenerative Disease | Best Researcher Award

Xi'an Children's Hospital | China 



Orcid ID


Ying Yang's academic journey began with a strong focus on science and medicine. Excelling in her studies from an early age, she displayed a keen interest in genetics and neurology. This passion led her to pursue a Bachelor's degree in Genetics, laying the foundation for her future research endeavors.


After completing her undergraduate studies, Ying Yang embarked on a path towards advanced research and academic excellence. She pursued a Master's degree, delving deeper into the intricacies of genetic disorders affecting the nervous system in children. Her dedication and commitment to her field were evident as she published several papers during this period, showcasing her burgeoning expertise.


Ying Yang's primary focus has always been on identifying pathogenic genes and elucidating the underlying mechanisms of hereditary diseases in pediatric neurology. Her research efforts have contributed significantly to the understanding of these complex disorders, providing crucial insights into their pathogenesis and potential therapeutic targets. Through her meticulous investigations, she has uncovered novel genetic mutations associated with various neurological conditions, advancing the field and paving the way for personalized medicine approaches.


Ying Yang's work has had a profound impact on both academia and clinical practice. Her findings have been widely cited and have informed clinical decision-making, ultimately improving patient care and outcomes. Furthermore, she has played an instrumental role in shaping the research landscape in her field, inspiring fellow scientists and students alike to explore the intersection of genetics and pediatric neurology.


Ying Yang's contributions to the field have been recognized through numerous citations in peer-reviewed journals and academic publications. Her research papers have served as fundamental references for researchers and clinicians working in pediatric neurology and genetics, further cementing her reputation as a leading authority in her area of expertise.


As Ying Yang continues to make strides in her research, her legacy as a pioneering scientist in pediatric neurology and genetics grows ever stronger. Her commitment to unraveling the mysteries of hereditary diseases in children serves as a beacon of inspiration for future generations of researchers. With her unwavering dedication and innovative approach, she is poised to make even greater contributions to the field, leaving an indelible mark on scientific knowledge and clinical practice for years to come.


Zhen Yan | Neuroscience | Best Researcher Award

Prof Zhen Yan | Neuroscience | Best Researcher Award

State University of New York at Buffalo | United States

Author Profile:


Orcid ID

Early Academic Pursuits:

Zhen Yan's academic journey began with a Bachelor’s degree in Biomedical Engineering from Xi’an Jiaotong University, China, followed by a Master’s degree in Computer Engineering from Southeast University, Nanjing, China. She then pursued her Ph.D. in Neurobiology at the University of Tennessee, College of Medicine, Memphis, TN, USA, under the mentorship of Dr. James Surmeier.

Professional Endeavors:

After completing her Ph.D., Zhen Yan embarked on a prolific academic career. She held various positions at the State University of New York (SUNY) at Buffalo, starting as a Postdoctoral Associate and eventually becoming a SUNY Distinguished Professor in the Department of Physiology and Biophysics. She also served as an Adjunct Faculty at the Roswell Park Cancer Institute, Buffalo, NY.

Contributions and Research Focus on Neuroscience:

Yan's research primarily focused on neurobiology, with a particular emphasis on neurodegenerative disorders such as Alzheimer's disease and autism. She investigated synaptic mechanisms, genetic factors, and epigenetic modifications underlying these conditions. Her work significantly contributed to understanding the pathophysiological mechanisms and identifying potential therapeutic targets for these disorders.

Impact and Influence:

Zhen Yan's contributions have been widely recognized in the scientific community. She received numerous awards and honors, including the National Parkinson Foundation Menek Goldstein Research Scholar Award and the SUNY Chancellor’s Awards for Excellence in Scholarship and Creative Activities. Her research findings have been published in prestigious journals and have influenced the field of neurobiology, particularly in the areas of Alzheimer's disease, autism, and synaptic physiology.

Academic Citations:

Yan's work has been cited extensively by her peers, indicating the significant impact of her research on the scientific community. Her publications have contributed to advancing knowledge in neurobiology and have served as a foundation for further studies in the field.

Legacy and Future Contributions:

As a distinguished professor and prolific researcher, Zhen Yan's legacy extends beyond her individual contributions. She has mentored numerous students and postdoctoral scholars, shaping the next generation of scientists. Her ongoing research continues to push the boundaries of neurobiology, offering hope for the development of novel therapies for neurodegenerative disorders and autism spectrum disorders.

Notable Publications: